Competition: Examining Regional Hubs and Strategic Partnerships in the Lentiviral Vector Contract Development Manufacturing Organization Market Region
The global nature of gene therapy development necessitates a manufacturing and supply chain infrastructure that can operate seamlessly across international borders. Companies developing therapies in North America often require vectors to be manufactured under European regulatory standards for clinical trials on that continent, highlighting the critical need for a geographically flexible...
0 Yorumlar 0 hisse senetleri 334 Views 0 önizleme